Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alitair Pharmaceuticals

Alitair Pharmaceuticals
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$115K LATEST DEAL AMOUNT
Description

Operator of a specialty pharmaceutical company intended to develop proprietary ion-exchange resin formulations, prescription cough medicines and a pipeline of orphan drugs. The company's patented formulation acts as a passive drug formulation system to reduce the risk of prescription drug overdose irrespective of the number of tablets or capsules ingested, enabling medical professionals to treat bronchiectasis easily and patients to get relief from respiration-related diseases quickly.

Website
Formerly Known As
The Cough Company
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 55 Madison Avenue
  • Suite 400
  • Morristown, NJ 07960
  • United States

+1 (973) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alitair Pharmaceuticals’s full profile, request a free trial.

Alitair Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 09-Oct-2018 $115K 00.000 Completed Generating Revenue
3. Angel (individual) 29-Jun-2017 000 00.00 Completed Generating Revenue
2. Angel (individual) 10-Feb-2017 $100K $100K Completed Generating Revenue
1. Angel (individual) 29-Sep-2015 $911K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Alitair Pharmaceuticals Executive Team (6)

Name Title Board
Seat
Contact
Info
James Hoyes Chief Executive Officer & Chairman
Helmut Albrecht MD Chief Scientific Officer
Frank Guarino Senior Vice President
Frank Koos Senior Vice President, Business Development

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Alitair Pharmaceuticals Board Members (3)

Name Representing Role Since Contact
Info
James Hoyes Alitair Pharmaceuticals Chief Executive Officer & Chairman 000 0000
Robert Casale Alitair Pharmaceuticals Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »